PHARMACYTE BIOTECH, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
PHARMACYTE BIOTECH, INC. (PMCB) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $8.97 thousand for the 12-month period ending 2025-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $8.97K, a 84.93% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $59.51K.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was -$8.46K.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was -$4.36K, a 330.55% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-04-30 | $8.97K 10-K · filed 2026-07-29 | |
| 2024-04-30 | $59.51K 10-K · filed 2025-08-11 | $59.49K 10-K · filed 2024-08-13 |
| 2023-04-30 | -$8.46K 10-K · filed 2024-08-13 | |
| 2022-04-30 | -$4.36K 10-K · filed 2023-07-31 | |
| 2021-04-30 | $1.89K 10-K · filed 2022-07-28 | |
| 2020-04-30 | -$56.37K 10-K · filed 2021-08-10 | |
| 2019-04-30 | $6.45K 10-K · filed 2020-08-13 | -$6.45K 10-K · filed 2019-08-13 |
| 2018-04-30 | -$147.74K 10-K · filed 2019-08-13 | |
| 2017-04-30 | -$124.89K 10-K · filed 2018-07-20 | |
| 2016-04-30 | $3.63K 10-K · filed 2017-07-27 | |
| 2015-04-30 | -$162.06K 10-K · filed 2016-07-29 | -$162.05K 10-K · filed 2015-07-29 |
| 2014-04-30 | $221.15K 10-K · filed 2016-07-29 | |
| 2013-04-30 | -$83.67K 10-K/A · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |